News: Clinical Trials

Next Page »

Detecting Lung Cancer Early

Monday, November 7th, 2011

Dr. Pierre Massion, associate professor of medicine and cancer biology at Vanderbilt-Ingram Cancer Center, explains why it is difficult to detect lung cancer at an early stage. He also describes the Nashville Lung Cancer Screening Trial and how he hopes the study will establish a better screening process. If you are interested in learning more [...]

VUMC Teams with 3 Midstate Hospitals

Friday, September 23rd, 2011

Leaders of Vanderbilt University Medical Center, Maury Regional Medical Center, Northcrest Medical Center and Williamson Medical Center today announced affiliation agreements establishing a partnership between these medical centers to work collaboratively to create new jointly operated programs and services in the counties where these hospitals reside. These programs are intended to expand primary and specialty [...]

Cancer Center Debuts Clinic in Green Hills

Friday, August 19th, 2011

Vanderbilt-Ingram Cancer Center has opened a free-standing cancer clinic in Green Hills to give cancer patients more options for their oncology care. VICC Green Hills provides many of the same services available at the main VICC campus, including access to board-certified cancer physicians and specially trained oncology nurses and pharmacists. Patients can see an oncologist, [...]

Get Your Creativity On!

Monday, July 25th, 2011

Calling all artists and artist-wanna-be’s! Each year, Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center show support for various cancer organizations by recruiting teams to participate in walks and runs. We like to design a special T-shirt to give our participants as a way to say thank you and to show the community that Vanderbilt [...]

Early Detection for Lung Cancer Saves Lives

Thursday, June 30th, 2011

Publication this week of results of the National Lung Screening Trial, which found screening with a type of low-dose CT scan could reduce death from lung cancer by as much as 20 percent, was met with excitement and hope from lung cancer survivors, advocates, caregivers, researchers and doctors. The study, sponsored by the National Institutes [...]

Never Give Up, Lance’s Mom Says

Thursday, June 23rd, 2011

In 1971 — coincidentally the year that President Nixon declared the War on Cancer — a 16-year-old gave birth in Plano, Texas, to a baby boy that she named Lance. He would grow up to become a champion cyclist and arguably the most famous cancer survivor on the planet. Dressed in the trademark yellow of [...]

Big Picture Moments

Wednesday, June 22nd, 2011

As a clinical trials nurse Wendy Cooper, B.S.N., R.N., has a ringside seat to the bench-to-bedside progress of cancer research. “We have brilliant minds who work on one pathway or one piece of the puzzle for their entire career,” said Cooper, the assistant director of clinical research operations for the Clinical Trials Shared Resource (CTSR) [...]

Cancer Survivors’ Day Highlights

Tuesday, June 21st, 2011

More than 350 cancer survivors, caregivers, advocates and health professionals gathered at the Vanderbilt Student Life Center last Saturday (June 18, 2011) to learn, connect and celebrate. Cancer GPS: Navigating Your Journey included remarks from keynote speaker Linda Armstrong Kelly (author and mother of champion cyclist and survivor Lance Armstrong), music and stories from survivor, [...]

Lung Cancer Screening Trial Opens

Friday, April 29th, 2011

Smokers and ex-smokers are at higher risk for developing lung cancer, but researchers still don’t know which individuals are most likely to develop the deadly disease. Now, these high-risk individuals who live in the Nashville area are eligible to participate in the Nashville Lung Cancer Screening Trial, a research project to determine which biomarkers could [...]

Breast Cancer Study Combines Therapies

Friday, March 18th, 2011

Combining targeted therapies might be required for maximum anti-tumor activity when treating HER2-positive breast cancers, according to two new studies by Vanderbilt-Ingram Cancer Center (VICC) investigators. The findings, reported in two papers in the Proceedings of the National Academy of Sciences (PNAS), suggest that upregulation of the HER3 receptor limits the effectiveness of two classes [...]